featured
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
American Journal of Respiratory and Critical Care Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial
Am J Respir Crit Care Med 2022 Mar 15;205(6)674-684, D Khanna, CJF Lin, DE Furst, B Wagner, M Zucchetto, G Raghu, FJ Martinez, J Goldin, J Siegel, CP DentonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.